Home › Drug Product Listings › Fentanyl

Fentanyl

Trade Name: 
Abstral
Manufacturer/Distributor: 
Paladin Labs
1-888-550-6060 www.paladinlabs.com/abstral
Classification: 
Opioid analgesic
ATC Class: 
N02AB03 - fentanyl
Status: 
active
Notice of Compliance (yyyy/mm/dd): 
2011/02/17
Date Marketed in Canada (yyyy/mm/dd): 
2011/06/13
Presentation: 
Sublingual tablet: 100 mcg. DIN: 02364174
Sublingual tablet: 200 mcg. DIN: 02364182
Sublingual tablet: 300 mcg. DIN: 02364190
Sublingual tablet: 400 mcg. DIN: 02364204
Sublingual tablet: 600 mcg. DIN: 02364212
Sublingual tablet: 800 mcg. DIN: 02364220
Comments: 
Sublingual tablets for use in adult cancer patients with breakthrough pain who are already receiving, or who are tolerant to, opioid therapy for their persistent baseline cancer pain.
Further Information: 
Paladin Labs Inc. has created the Abstral Education Programme to mitigate the risk of overdose, abuse, addiction and serious complications due to medication errors by: helping to assure proper patient selection; reducing the risk of exposure in persons for whom it was not prescribed; training prescribers, pharmacists, and patients about proper dosing and administration. These educational materials are available from the Paladin website.
Back to: 
Drug Product Listings
  • Share this
  • Printer-friendly version
  • PDF version